The Department of Justice (DOJ) on Monday filed a petition asking the Supreme Court to take up a dispute about access to the abortion pill Mifeprex, its generic version mifepristone. The petition seeks to overturn a decision from the 9th U.S. Circuit Court of Appeals, which ruled in April that a Trump administration policy blocking access to the drug was unconstitutional. Under the policy, the drug was only available in limited circumstances through healthcare providers who had a special agreement with the government. The DOJ argued in its petition that the 9th Circuit Court wrongly interpreted the law and that the policy was intended to protect against potential risks associated with the drug. If the Supreme Court takes up the case, it could have far-reaching implications for women’s access to abortion care.
Disclaimer: InformedAmericanToday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.